Open Access

CASE REPORT

Transcatheter Device Closure of a Perimembranous Ventricular Septal Defect in Congenitally Corrected Transposition of the Great Arteries

by Catherine E. Tomasulo^1,*, Lindsay S. Rogers¹, Lauren Andrade^1,2, Michael L. O’Byrne^1,3,4

1 Division of Cardiology, The Children’s Hospital of Philadelphia, Philadelphia, USA
2 Division of Cardiology, Hospital of the University of Pennsylvania, Philadelphia, USA
3 Center for Pediatric Clinical Effectiveness, The Children’s Hospital of Philadelphia, Philadelphia, USA
4 Leonard Davis Institute and Center for Cardiovascular Outcomes, Quality, and Evaluative Research, University of Pennsylvania, Philadelphia, USA

* Corresponding Author: Catherine E. Tomasulo. Email:

Congenital Heart Disease 2022, 17(2), 193-199. https://doi.org/10.32604/chd.2022.017721

Received 01 June 2021; Accepted 10 August 2021; Issue published 26 January 2022

Abstract

The majority of patients with congenitally corrected transposition of the great arteries, also known as transposition of the great arteries {S,L,L} have ventricular septal defects (VSD), most commonly perimembranous VSD (pmVSD). Transcatheter device closure of pmVSD in these patients has not been widely described. We present a case of device closure of pmVSD in L-TGA with an Amplatzer Duct Occluder II (ADOII) device using a deployment starting in the subpulmonary left ventricle. The case demonstrates some of the technical advantages of the ADOII device for VSD closure, specifically its low profile, symmetric shape, and soft material. These characteristics are advantageous in closing conventional pmVSD but are especially useful in patients with challenging anatomic substrates.

---

Keywords

---